Provided are amine salts of {4,6-bis(dimethylamino)-2-(4-(4- (trifluoromethyl)benzamido)benzyl)pyrimidin-5-yl} -acetic acid, processes for their preparation, pharmaceutical compositions containing them, and their use for treating, preventing, or ameliorating one or more symptoms of a CRTH2-mediated disorder or disease.